Remove tag relevance
article thumbnail

New approach to improving clinical trial enrollment and diversity

Medical Xpress

Failure to enroll enough participants in trials can delay the arrival of new therapies in the clinic and inflate their eventual price tags. Failure to recruit diverse patients could diminish the relevance and generalizability of trial findings.

article thumbnail

Google’s 2021 Title Shakeup Part 2: Our SERP Title Analysis Study

Intouch Solutions

blue links) of the organic results appeared to be pulling from content outside of the HTML title tag at a much higher frequency. SERP Titles vs H1 Elements Comparisons: SERP Titles were compared to the page’s title tag and H1 element for each date range. Create highly relevant titles to limit rewrites from Google.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Google’s 2021 Title Shakeup Part 1: What Pharma Marketers Should Know

Intouch Solutions

blue links) of the organic results appeared to be pulling from content outside of the HTML title tag at a much higher frequency. Title Tag – This is an HTML element that provides a title for the page. The title tag is not otherwise visible to users on the page. Specifically, title links (i.e., The SERP Title is the blue link.

article thumbnail

September 30, 2022: CTTI’s Digital Health Trials Hub Recommendations and Resources to Run Your Digital Health Trial (Marianne Chase, MGH, CTTI Team Lead, Jörg Goldhahn, ETH Zurich, CTTI Team Lead)

Rethinking Clinical Trials

CTTI wants to increase meaningful novel digital endpoints that are clinically relevant and fit-for-purpose. DCTs range from near-traditional to hybrid to fully remote trials that conduct study visits away from the central study site using strategies such as tele-visits or home delivery of investigational products. pctGR, @Collaboratory1.

Trials 130
article thumbnail

June 24, 2022: FDA Draft Guidance on Real-World Evidence (John Concato, MD, MS, MPH)

Rethinking Clinical Trials

From the FDA point-of-view, while reliability can be more readily evaluated and would tend to be more stable, the relevance to a particular study could not be determined as easily. . – Could real-world data sources be certified and preclude the need for submission of source data on a study specific basis? pctGR, @Collaboratory1.

Big Data 130
article thumbnail

Almirall and IRB Barcelona team up to tackle skin disease

pharmaphorum

The use of monovalent degraders, which enable the targeted degradation of disease-relevant proteins, offers a new avenue to reach tissue that cannot be targeted with conventional therapeutic agents. Researchers at Almirall have identified several proteins whose abnormal function is associated with inflammatory immune skin diseases.

article thumbnail

Grand Rounds October 13, 2023: Incorporating Social Determinants of Health Into PCORnet (Keith Marsolo, PhD)

Rethinking Clinical Trials

Partners then must find the relevant measures within their EHRs and harmonizing them to the appropriate code. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 13, 2023: Incorporating Social Determinants of Health Into PCORnet (Keith Marsolo, PhD) appeared first on Rethinking Clinical Trials.